Diabetes Technology

Latest News

Closed-Loop System Better Controls Blood Glucose Than Sensor-Augmented Insulin Pump

By

Amit Akirov, MD

A closed-loop insulin delivery system, also referred to as an artificial pancreas, was found to be more effective than sensor-augmented insulin pump therapy in patients with type 1 diabetes.

Fast-Acting Insulin Approved for Use in Insulin Infusion Pumps

By

Brian Park, PharmD

The FDA has expanded the indication for Fiasp (insulin aspart injection; Novo Nordisk) 100 Units/mL to include use in insulin infusion pumps to improve glycemic control in adults with type 1 or type 2 diabetes.

Comparison of Faster vs Standard Insulin Aspart in Fully Closed-Loop Insulin Therapy

By

Amit Akirov, MD

There were no clear benefits of using faster insulin aspart in closed-loop insulin therapy and the closed-loop algorithm was better adjusted to the use of standard insulin aspart.

FDA: Insulin Pumps Could Be Hacking Targets

Medical devices that can connect to the internet might be at risk for hacking, the U.S. Food and Drug Administration warned Tuesday.

Examining Potential Allergens in Adhesives Used for Diabetes Devices

By

Tyler Rice

Colophonium, a fast-acting adhesive and known sensitizing allergen, may cause dermatologic reactions in children using devices to manage diabetes.

Use of Insulin Pump Therapy, CGM Increasing in Type 1 Diabetes

Highest rates reported among preschoolers, children, and adolescents aged younger than 15 years

Real-World Data Show Implantable Glucose Sensor Is Safe, Effective in First Commercial Users

By

Morgan E. Meissner

Real-world usage of an implantable continuous glucose monitoring system shows promise for improved glycemic control, sensor accuracy, and safety.

FDA Approves HbA1c Monitoring Device With Discreet Blood Sample Collection

By

Steve Duffy

The FDA has granted 510(k) market clearance to the OneDraw A1C Test system, which monitors HbA1c levels in individuals with diabetes for long-term glucose control.

Key Recommendations for Diabetes Technology: ADA 2019 Standards of Care

By

Amit Akirov, MD

A review published in the Annals of Internal Medicine outlines the 2019 ADA guidelines for self-monitoring of blood glucose and the use of continuous glucose monitors and automated insulin delivery systems.

How Crowd-Sourced “Looping” Technology Is Changing Care for Type 1 Diabetes

By

Endocrinology Advisor Contributing Writer

Years before the first closed-loop insulin delivery system was approved, patients with diabetes had already been implementing the technology into their own care.

Smartphone Apps for T2D Self-Management Lack Decision Support, Patient Education

By

Tyler Rice

Few smartphone apps for self-management of type 2 diabetes provide sufficient real-time action prompts or education on blood glucose monitoring.